Literature DB >> 32659037

Multiparameter Kinetic Analysis for Covalent Fragment Optimization by Using Quantitative Irreversible Tethering (qIT).

Gregory B Craven1,2, Dominic P Affron2, Teresa Kösel2, Tsz Lam M Wong1, Zoë H Jukes1, Chun-Ting Liu2, Rhodri M L Morgan1, Alan Armstrong2, David J Mann1.   

Abstract

Chemical probes that covalently modify cysteine residues in a protein-specific manner are valuable tools for biological investigations. Covalent fragments are increasingly implemented as probe starting points, but the complex relationship between fragment structure and binding kinetics makes covalent fragment optimization uniquely challenging. We describe a new technique in covalent probe discovery that enables data-driven optimization of covalent fragment potency and selectivity. This platform extends beyond the existing repertoire of methods for identifying covalent fragment hits by facilitating rapid multiparameter kinetic analysis of covalent structure-activity relationships through the simultaneous determination of Ki , kinact and intrinsic reactivity. By applying this approach to develop novel probes against electrophile-sensitive kinases, we showcase the utility of the platform in hit identification and highlight how multiparameter kinetic analysis enabled a successful fragment-merging strategy.
© 2020 The Authors. Published by Wiley-VCH GmbH.

Entities:  

Keywords:  Cdk2; covalent fragments; covalent inhibition kinetics; electrophile-sensitive inhibition; fragment-based drug discovery

Mesh:

Substances:

Year:  2020        PMID: 32659037      PMCID: PMC7754465          DOI: 10.1002/cbic.202000457

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  27 in total

Review 1.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry.

Authors:  Benjamin F Cravatt; Aaron T Wright; John W Kozarich
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 2.  Reactive-cysteine profiling for drug discovery.

Authors:  Aaron J Maurais; Eranthie Weerapana
Journal:  Curr Opin Chem Biol       Date:  2019-03-18       Impact factor: 8.822

3.  Compound Design by Fragment-Linking.

Authors:  Osamu Ichihara; John Barker; Richard J Law; Mark Whittaker
Journal:  Mol Inform       Date:  2011-04-06       Impact factor: 3.353

4.  Global profiling of lysine reactivity and ligandability in the human proteome.

Authors:  Stephan M Hacker; Keriann M Backus; Michael R Lazear; Stefano Forli; Bruno E Correia; Benjamin F Cravatt
Journal:  Nat Chem       Date:  2017-07-31       Impact factor: 24.427

5.  The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors.

Authors:  Rasmus Hansen; Ulf Peters; Anjali Babbar; Yuching Chen; Jun Feng; Matthew R Janes; Lian-Sheng Li; Pingda Ren; Yi Liu; Patrick P Zarrinkar
Journal:  Nat Struct Mol Biol       Date:  2018-05-14       Impact factor: 15.369

Review 6.  Covalent fragment libraries in drug discovery.

Authors:  Aaron Keeley; László Petri; Péter Ábrányi-Balogh; György M Keserű
Journal:  Drug Discov Today       Date:  2020-04-13       Impact factor: 7.851

7.  Chemical genetic strategy for targeting protein kinases based on covalent complementarity.

Authors:  Adam L Garske; Ulf Peters; Arianna T Cortesi; Jenny L Perez; Kevan M Shokat
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-18       Impact factor: 11.205

8.  Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.

Authors:  Mark E Flanagan; Joseph A Abramite; Dennis P Anderson; Ann Aulabaugh; Upendra P Dahal; Adam M Gilbert; Chao Li; Justin Montgomery; Stacey R Oppenheimer; Tim Ryder; Brandon P Schuff; Daniel P Uccello; Gregory S Walker; Yan Wu; Matthew F Brown; Jinshan M Chen; Matthew M Hayward; Mark C Noe; R Scott Obach; Laurence Philippe; Veerabahu Shanmugasundaram; Michael J Shapiro; Jeremy Starr; Justin Stroh; Ye Che
Journal:  J Med Chem       Date:  2014-11-26       Impact factor: 7.446

9.  A Chemical-Genetic Approach to Generate Selective Covalent Inhibitors of Protein Kinases.

Authors:  Alvin Kung; Marianne Schimpl; Arunika Ekanayake; Ying-Chu Chen; Ross Overman; Chao Zhang
Journal:  ACS Chem Biol       Date:  2017-05-08       Impact factor: 5.100

10.  High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery.

Authors:  Gregory B Craven; Dominic P Affron; Charlotte E Allen; Stefan Matthies; Joe G Greener; Rhodri M L Morgan; Edward W Tate; Alan Armstrong; David J Mann
Journal:  Angew Chem Int Ed Engl       Date:  2018-03-26       Impact factor: 15.336

View more
  3 in total

1.  Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease.

Authors:  Bo Qin; Gregory B Craven; Pengjiao Hou; Julian Chesti; Xinran Lu; Emma S Child; Rhodri M L Morgan; Wenchao Niu; Lina Zhao; Alan Armstrong; David J Mann; Sheng Cui
Journal:  Acta Pharm Sin B       Date:  2022-06-09       Impact factor: 14.903

2.  Quantitative Irreversible Tethering (qIT) for Target-directed Covalent Fragment Screening.

Authors:  Gregory B Craven; Alan Armstrong; David J Mann
Journal:  Bio Protoc       Date:  2020-12-20

3.  Multiparameter Kinetic Analysis for Covalent Fragment Optimization by Using Quantitative Irreversible Tethering (qIT).

Authors:  Gregory B Craven; Dominic P Affron; Teresa Kösel; Tsz Lam M Wong; Zoë H Jukes; Chun-Ting Liu; Rhodri M L Morgan; Alan Armstrong; David J Mann
Journal:  Chembiochem       Date:  2020-08-07       Impact factor: 3.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.